fibrinogen has been researched along with Cancer of Ovary in 64 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (46.88) | 18.7374 |
1990's | 7 (10.94) | 18.2507 |
2000's | 8 (12.50) | 29.6817 |
2010's | 17 (26.56) | 24.3611 |
2020's | 2 (3.13) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Shan, B; Yang, H; Ye, S; Zhou, S | 1 |
Huang, M; Jin, C; Wang, Y; Yao, W; Zhang, Y; Zheng, R; Zhou, J | 1 |
Ding, S; Li, T; Lin, Q; Wang, J; Zhang, X; Zhu, L; Zhu, T | 1 |
Kim, HS; Kim, M; Lee, M; Luo, Y; Song, YS | 1 |
Asada, R; Fukuda, T; Honda, KI; Ishiko, O; Kageyama, K; Koyama, M; Sugawa, T; Sumi, T; Terada, H; Yasui, T | 1 |
Aust, S; D'Andrea, D; Grimm, C; Helmy-Bader, S; Polterauer, S; Reinthaller, A; Reiser, E; Seebacher, V; Tiringer, D; Von Mersi, H | 1 |
Benedetti Panici, P; Di Donato, V; Marchetti, C; Musella, A; Muzii, L; Palaia, I; Perniola, G; Romito, A; Santo, G | 1 |
Amirkhosravi, A; Bigsby, G; Coll, E; Desai, H; Faust, P; Francis, JL; Langer, F; Meyer, T; Reyes, E; Rivera-Amaya, M; Robles-Carrillo, L; Waters, A | 1 |
Chmaj-Wierzchowska, K; Kampioni, M; Opala, T; Wilczak, M | 1 |
Hao, J; Liu, C; Liu, X; Man, YN; Wang, YN; Wu, XZ; Zhu, C | 1 |
Grimm, C; Hefler, L; Hefler-Frischmuth, K; Lafleur, J; Polterauer, S; Reinthaller, A; Seebacher, V | 1 |
Chmaj-Wierzchowska, K; Kampioni, M; Opala, T; Sajdak, S; Wilczak, M | 1 |
Watrowski, R; Zeillinger, R | 1 |
Buda, A; Dell'Orto, F; Fruscio, R; Ghelardi, A; Guelfi, F; La Manna, M; Milani, R | 1 |
Bi, R; Duan, Y; Feng, Z; Wen, H; Wu, X; Yang, W | 1 |
Cárdenas-Rebollo, JM; Chuang, L; Martin Marfil, P; Minig, L; Patrono, MG; Rodriguez-Tabares, V | 1 |
Li, CY; Wu, M; Yuan, JY | 1 |
Concin, N; Grimm, C; Hefler, L; Hefler-Frischmuth, K; Husslein, H; Leipold, H; Marth, C; Polterauer, S; Reinthaller, A; Seebacher, V; Tempfer, C; Tomovski, C | 1 |
De Iaco, P; Di Marcoberardino, B; Orazi, L; Pozzati, F; Ricci Maccarini, L; Rossi, M; Strada, I; Tsivian, M; Venturoli, S | 1 |
Fu, Y; Lu, W; Qiu, J; Xie, X; Ye, F; Yu, Y | 1 |
Betti, M; Buda, A; Fruscio, R; Milani, R; Pirovano, C; Signorelli, M | 1 |
Gramignano, G; Lusso, MR; Macciò, A; Madeddu, C; Mantovani, G; Massa, D; Melis, GB; Mudu, MC; Serpe, R | 1 |
Choolani, M; Ilancheran, A; Khalil, R; Koh, SC; Lim, FK | 1 |
Guo, T; Hu, Y; Wei, W; Yang, R; Yang, Y | 1 |
Rajapakse, S; Takahashi, T | 1 |
Gollwitzer, R; Graeff, H; Hafter, R; Klaubert, W; von Hugo, R | 1 |
Khachaturova, TS; Mkrtchian, LN; Shukurian, SG | 1 |
Kagiya, A; Kikuchi, M; Shinagawa, S; Takano, A | 1 |
Clarke-Pearson, DL; Gore, M; Miller, KE; Pizzo, SV; Soong, SJ | 1 |
Gollwitzer, R; Graeff, H; Hafter, R; Klaubert, E; Klaubert, W; von Hugo, R | 1 |
Crandon, AJ; Koutts, J | 1 |
Chekhova, EI; Filatovich, LN; Nodel'son, SE; Shitikov, BD; Vishnevskaia, EE | 1 |
Kaibara, M; Kobayashi, T; Marumoto, Y; Taniguchi, I | 1 |
Maggino, T; Marchesoni, D; Marchetti, M; Menighetti, M; Paternoster, D; Tredese, F; Valente, S | 1 |
Gallus, AS; McCulloch, PB; Pineo, GF; Williams, CK | 1 |
Carreiras, F; Gauduchon, P; Le Talaer, JY; Lehmann, M; Marvaldi, J; Sichel, F | 1 |
Dvorak, HF; Herzberg, KT; Masse, EM; Meyers, MS; Nagy, JA | 1 |
Nagano, T; Ozawa, M; Sugitachi, A; Suzuki, A | 1 |
Bernadou, A; Mirshahi, M; Mirshahi, SS; Moreau, JF; Pujade-Lauraine, E; Soria, C; Soria, J; Taupin, JL; Vasse, M | 1 |
Heilmann, L; Hommel, G; Kirkpatrick, CJ; Niemann, F; Schneider, DM; von Tempelhoff, GF | 1 |
Heilmann, L; Hommel, G; Nieman, F; von Tempelhoff, GF | 1 |
Aoki, Y; Kurabayashi, T; Matsushita, H; Tanaka, K; Tomita, M; Yamamoto, Y | 1 |
Astedt, B; Svanberg, L | 1 |
Chumnijarakij, T; Poshyachinda, V | 1 |
Schultz, DR; Wu, MC; Yunis, AA | 1 |
Hörmann, H; Stemberger, AW | 1 |
Astedt, B; Linell, F; Pandolfi, M; Svanberg, L | 1 |
Graeff, H; Hafter, R; Henschen, A; Schmitt, M; Wilhelm, O | 1 |
Nakanishi, M; Narumiya, H; Noguchi, M; Sawaguchi, K; Yabushita, H | 1 |
Krantz, S; Lober, M; Lober, R | 1 |
Heilmann, L; Miller, B | 1 |
Benedetti Panici, P; Bompiani, A; Di Roberto, P; Laghi, F; Mancuso, S; Margariti, PA; Scambia, G | 1 |
Baicchi, U; Del Bravo, B; Facchini, V; Fioretti, P; Gadducci, A; Teti, G; Vispi, M | 1 |
Ino, Y | 1 |
Cochan Priollet, B; Haguenau, M; Lecoz, P; Mikol, J; Moulinier, L; Pépin, B; Soria, C; Woimant, F | 1 |
Franke, M; Graeff, H; Hafter, R; Röbl, M; von Hugo, R | 1 |
Astedt, B; Nilsson, IM; Svanberg, L | 1 |
Colman, RW; Mosesson, MW; Sherry, S | 1 |
Sato, GH; Schultz, DR; Yunis, AA | 1 |
Astedt, B; Gynning, I; Nilsson, IM; Svanberg, L | 1 |
Schander, K; Schneider, J; Ventocilla, B | 1 |
Faivre, J; Favre-Gilly, J; Michel, D; Schott, B; Tommasi, M | 1 |
Bonnar, J; Walsh, JJ; Wright, FW | 1 |
Yamamoto, M | 1 |
2 review(s) available for fibrinogen and Cancer of Ovary
Article | Year |
---|---|
Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Cohort Studies; Disease-Free Survival; Female; Fibrinogen; Humans; Lymphocyte Count; Middle Aged; Neoplasms, Glandular and Epithelial; Neutrophils; Ovarian Neoplasms; Predictive Value of Tests; Prognosis; Young Adult | 2017 |
[Cancer chemotherapy and blood coagulation-fibrinolysis system].
Topics: Adult; Antineoplastic Agents; Blood Coagulation; Blood Coagulation Factors; Breast Neoplasms; Dextrans; Female; Fibrin; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Rectal Neoplasms; Sulfates | 1971 |
62 other study(ies) available for fibrinogen and Cancer of Ovary
Article | Year |
---|---|
Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma.
Topics: Adenocarcinoma, Clear Cell; Adult; Antineoplastic Agents; Biomarkers, Tumor; CA-125 Antigen; Cytoreduction Surgical Procedures; Drug Monitoring; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Membrane Proteins; Middle Aged; Ovarian Neoplasms; Ovary; Platinum Compounds; Predictive Value of Tests; Preoperative Period; Proportional Hazards Models; Retrospective Studies; ROC Curve; Serum Albumin; Treatment Outcome; WAP Four-Disulfide Core Domain Protein 2 | 2022 |
MiR-30a-5p Enhances Cisplatin Sensitivity by Downregulating RIF1 in Ovarian Cancer.
Topics: Apoptosis; Cisplatin; Drug Resistance, Neoplasm; Female; Fibrinogen; Humans; MicroRNAs; Ovarian Neoplasms; Telomere-Binding Proteins | 2023 |
Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis?
Topics: Adult; Area Under Curve; Biomarkers; Blood Coagulation; C-Reactive Protein; CA-125 Antigen; Endometriosis; Female; Fibrinogen; Humans; Inflammation Mediators; Laparoscopy; Lymphocyte Count; Neutrophils; Ovarian Cysts; Ovarian Diseases; Ovarian Neoplasms; Platelet Count; Thrombin Time | 2019 |
Protein Complex of Fibrinogen Gamma Chain and Complement Factor H in Ovarian Cancer Patient Plasma.
Topics: Complement Factor H; Female; Fibrinogen; Humans; Ovarian Neoplasms; Plasma | 2017 |
Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen.
Topics: Adnexal Diseases; Adult; Biomarkers, Tumor; Female; Fibrinogen; Humans; Middle Aged; Ovarian Neoplasms; Retrospective Studies; Risk | 2017 |
Combined Plasma Fibrinogen and Neutrophil Lymphocyte Ratio in Ovarian Cancer Prognosis May Play a Role?
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Fibrinogen; Humans; Lymphocyte Count; Middle Aged; Ovarian Neoplasms; Prognosis; Retrospective Studies; Rome | 2018 |
Blood clotting activation analysis for preoperative differentiation of benign versus malignant ovarian masses.
Topics: Adult; Aged; Biomarkers, Tumor; Blood Coagulation; CA-125 Antigen; Diagnosis, Differential; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Middle Aged; Ovarian Neoplasms; Preoperative Period; Sensitivity and Specificity; Thrombelastography; Thromboplastin | 2013 |
Do inflammatory factors play a significant role in etiopathogenesis of endometrial cysts? Part 1.
Topics: Adult; C-Reactive Protein; CA-125 Antigen; Chemokine CCL5; Cysts; Female; Fibrinogen; Gene Expression; Gene Expression Regulation; Humans; Inflammation; Leukocyte Count; Ovarian Neoplasms; Teratoma; Uterine Diseases | 2013 |
Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism.
Topics: Adult; Aged; Aged, 80 and over; Blood Platelets; Cystadenocarcinoma, Serous; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Prevalence; Prognosis; Survival Rate; Venous Thromboembolism | 2015 |
Plasma fibrinogen levels in patients with benign and malignant ovarian tumors.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Diagnosis, Differential; Female; Fibrinogen; Humans; Logistic Models; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2015 |
Novel markers in the diagnostics of endometriomas: Urocortin, ghrelin, and leptin or leukocytes, fibrinogen, and CA-125?
Topics: Adolescent; Adult; Biomarkers; CA-125 Antigen; Endometriosis; Female; Fibrinogen; Ghrelin; Humans; Leptin; Leukocyte Count; Ovarian Neoplasms; Sensitivity and Specificity; Teratoma; Urocortins; Young Adult | 2015 |
Simple laboratory score improves the preoperative diagnosis of adnexal mass.
Topics: Adnexa Uteri; Aged; Biomarkers, Tumor; C-Reactive Protein; CA-125 Antigen; Female; Fibrinogen; Humans; Membrane Proteins; Middle Aged; Ovarian Neoplasms; Platelet Count; Predictive Value of Tests; Preoperative Period | 2016 |
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: a double institution observational study.
Topics: Aged; Aged, 80 and over; Cellulitis; Drug Combinations; Female; Fibrinogen; Groin; Historically Controlled Study; Humans; Lymph Node Excision; Lymphedema; Lymphocele; Middle Aged; Ovarian Neoplasms; Postoperative Complications; Prospective Studies; Surgical Wound Dehiscence; Surgical Wound Infection; Thrombin; Vulvar Neoplasms | 2016 |
Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
Topics: Adult; Aged; CA-125 Antigen; Cystadenocarcinoma, Serous; Disease-Free Survival; Female; Fibrinogen; Humans; Membrane Proteins; Middle Aged; Ovarian Neoplasms; Platelet Count; Prognosis; Retrospective Studies; Thrombocytosis | 2016 |
Use of TachoSil® to Prevent Symptomatic Lymphocele after an Aggressive Tumor Debulking with Lymphadenectomy for Advanced Stage Ovarian Cancer. A Pilot Study.
Topics: Aged; Cytoreduction Surgical Procedures; Drug Combinations; Female; Fibrinogen; Humans; Longitudinal Studies; Lymphocele; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Pilot Projects; Retrospective Studies; Surgical Sponges; Thrombin | 2016 |
[Effects of platelet and fibrinogen on progressive ovarian cancer].
Topics: Adult; Aged; Cystadenocarcinoma, Serous; Female; Fibrinogen; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platelet Count; Young Adult | 2009 |
Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study.
Topics: Age Factors; Analysis of Variance; Antigens, Neoplasm; Biomarkers, Tumor; C-Reactive Protein; Disease-Free Survival; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Prognosis; Proportional Hazards Models; Retrospective Studies | 2009 |
[Fibrinogen and thrombin coated patch use on collagen support for lymphocele prevention after lumbar-aortic lymphadenectomy in gynecological neoplasms].
Topics: Adult; Carcinoma; Collagen; Drug Combinations; Endometrial Neoplasms; Female; Fibrinogen; Genital Neoplasms, Female; Hemostatics; Humans; Hysterectomy, Vaginal; Lumbosacral Region; Lymph Node Excision; Lymphocele; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Pelvis; Surgical Sponges; Thrombin; Time Factors; Treatment Outcome | 2011 |
Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Female; Fibrinogen; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platelet Count; Prognosis; Retrospective Studies | 2012 |
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy.
Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Breast Neoplasms; Case-Control Studies; Cellulitis; Drainage; Drug Combinations; Female; Fibrinogen; Groin; Humans; Lymph Node Excision; Lymphedema; Lymphocele; Middle Aged; Ovarian Neoplasms; Surgical Sponges; Surgical Wound Dehiscence; Surgical Wound Infection; Thrombin; Vulvar Neoplasms | 2012 |
Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia.
Topics: Aged; Aged, 80 and over; Anemia; Biomarkers; C-Reactive Protein; Epithelial Cells; Erythrocyte Count; Female; Ferritins; Fibrinogen; Glutathione Peroxidase; Hemoglobins; Humans; Interleukin-1; Interleukin-6; Iron; Leptin; Middle Aged; Ovarian Neoplasms; Reactive Oxygen Species; Reticulocyte Count; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2005 |
The association between fibrinogen, von Willebrand Factor, antithrombin III, and D-dimer levels and survival outcome by 36 months from ovarian cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithrombin III; Biomarkers; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Middle Aged; Ovarian Neoplasms; Prognosis; Survival Analysis; von Willebrand Factor | 2006 |
Fribrinolysis kinetics and its application.
Topics: Adolescent; Adult; Blood Coagulation; Case-Control Studies; Cell Line, Tumor; Clinical Protocols; Crotalid Venoms; Drug Monitoring; Female; Fibrinogen; Fibrinolysis; Humans; Kinetics; Leukemia, Myeloid, Acute; Male; Middle Aged; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reproducibility of Results; Spectrophotometry, Ultraviolet; Thrombin; Time Factors; Transfection; Urokinase-Type Plasminogen Activator | 2007 |
Expression and enzymatic characterization of recombinant human kallikrein 14.
Topics: Biomarkers, Tumor; Caseins; Collagen Type I; Collagen Type IV; Extracellular Matrix Proteins; Female; Fibrinogen; Fibronectins; Gelatin; Humans; Insulin-Like Growth Factor Binding Protein 3; Kallikreins; Ovarian Neoplasms; Recombinant Proteins; Serine Endopeptidases; Serine Proteinase Inhibitors; Substrate Specificity | 2007 |
Crosslinked fibrin derivatives and fibronectin in ascitic fluid from patients with ovarian cancer compared to ascitic fluid in liver cirrhosis.
Topics: Ascitic Fluid; Densitometry; Electrophoresis, Polyacrylamide Gel; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibronectins; Humans; Liver Cirrhosis, Alcoholic; Ovarian Neoplasms | 1984 |
[Fibrin deposits on the surface of tumorous and normal cells].
Topics: Amnion; Cell Line; Cells, Cultured; Female; Fibrin; Fibrinogen; Histocytochemistry; Humans; Microscopy, Electron; Microscopy, Fluorescence; Ovarian Neoplasms | 1984 |
Gynecological malignancies and disseminated intravascular coagulation.
Topics: Adult; Aged; Blood Sedimentation; Choriocarcinoma; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genital Neoplasms, Female; Humans; Middle Aged; Ovarian Neoplasms; Pregnancy; Uterine Cervical Neoplasms; Uterine Neoplasms | 1984 |
Vascular plasminogen activator levels and thromboembolic disease in patients with gynecologic malignancies.
Topics: Female; Fibrinogen; Genital Neoplasms, Female; Humans; Iodine Radioisotopes; Ovarian Neoplasms; Plasminogen Activators; Plethysmography, Impedance; Postoperative Complications; Thromboembolism; Uterine Neoplasms | 1984 |
[Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis].
Topics: Ascites; Ascitic Fluid; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Liver Cirrhosis; Ovarian Neoplasms | 1983 |
Incidence of post-operative deep vein thrombosis in gynaecological oncology.
Topics: Female; Fibrinogen; Humans; Hysterectomy; Iodine Radioisotopes; Leg; Lymph Node Excision; Ovarian Neoplasms; Postoperative Complications; Prospective Studies; Radionuclide Imaging; Smoking; Thrombophlebitis; Time Factors; Uterine Cervical Neoplasms; Uterine Neoplasms | 1983 |
[Postoperative thrombosis of the deep veins of the legs in cancer patients].
Topics: Adult; Aged; Female; Fibrinogen; Genital Neoplasms, Female; Humans; Iodine Radioisotopes; Leg; Middle Aged; Ovarian Neoplasms; Postoperative Complications; Pulmonary Embolism; Radionuclide Imaging; Thrombophlebitis; Uterine Cervical Neoplasms; Uterine Neoplasms | 1981 |
[Clinical studies on flow properties of blood in the gynecological patients with potentially hypercoagulable state (author's transl)].
Topics: Adult; Blood Viscosity; Female; Fibrinogen; Genital Diseases, Female; Humans; Hysterectomy; Leiomyoma; Middle Aged; Ovarian Neoplasms; Postoperative Period; Thromboembolism; Uterine Neoplasms | 1981 |
Fibrinolysis in ovarian cancer.
Topics: Antithrombins; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Ovarian Neoplasms | 1981 |
The relevance of platelet and fibrinogen kinetics and coagulation studies to extent of disease and performance status in patients with adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Blood Coagulation; Blood Platelets; Breast Neoplasms; Colonic Neoplasms; Female; Fibrinogen; Half-Life; Humans; Kinetics; Male; Middle Aged; Ovarian Neoplasms | 1980 |
Implication of the alpha v beta 3 integrin in the adhesion of the ovarian-adenocarcinoma cell line IGROV1.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Cell Adhesion; Female; Fibrinogen; Fluorescent Antibody Technique; Humans; Macromolecular Substances; Ovarian Neoplasms; Rats; Receptors, Vitronectin; Tumor Cells, Cultured; Vitronectin | 1995 |
Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity.
Topics: Animals; Ascites; Capillary Permeability; Female; Fibrin; Fibrinogen; Iodine Radioisotopes; Male; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Muscle, Skeletal; Ovarian Neoplasms; Peritoneal Cavity; Peritoneum | 1995 |
[A case report of stage IV ovarian carcinoma treated with cancer chemotherapy and surgery].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Delayed-Action Preparations; Doxorubicin; Endometriosis; Factor XIII; Female; Fibrinogen; Humans; Lidocaine; Middle Aged; Ovarian Neoplasms; Ovariectomy; Thrombin | 1993 |
Incubation of monocytes with adriamycin increases secretion of hepatocyte stimulating factor for fibrinogen biosynthesis.
Topics: Cells, Cultured; Culture Media; Doxorubicin; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Growth Inhibitors; Humans; Interleukin-6; Leukemia Inhibitory Factor; Lymphokines; Monocytes; Ovarian Neoplasms | 1993 |
Blood rheology during chemotherapy in patients with ovarian cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Viscosity; Cisplatin; Cyclophosphamide; Epirubicin; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Hemoglobins; Hemorheology; Heparin, Low-Molecular-Weight; Humans; Leukocyte Count; Middle Aged; Ovarian Neoplasms; Platelet Count; Prospective Studies; Thrombophlebitis | 1998 |
Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
Topics: Adult; Aged; Antineoplastic Agents; Blood Cell Count; Blood Viscosity; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cohort Studies; Disease Progression; Erythrocyte Aggregation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Genital Neoplasms, Female; Germany; Hematocrit; Hemorheology; Humans; Life Tables; Microcirculation; Middle Aged; Neoplasm Metastasis; Neoplastic Cells, Circulating; Ovarian Neoplasms; Prospective Studies; Risk Factors; Survival Analysis; Thrombophilia; Uterine Cervical Neoplasms; Uterine Neoplasms; Venous Thrombosis | 2000 |
Disseminated intravascular coagulation associated with intratumoral hemorrhage of ovarian cancer.
Topics: Adult; CA-125 Antigen; CA-19-9 Antigen; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemoglobins; Hemorrhage; Humans; Magnetic Resonance Imaging; Ovarian Neoplasms; Platelet Count; Tomography, X-Ray Computed | 2001 |
Coagulative and fibrinolytic properties of ascitic fluid associated with ovarian tumors.
Topics: Alpha-Globulins; Antithrombins; Ascitic Fluid; Coagulants; Factor V; Factor VIII; Female; Fibrinogen; Fibrinolytic Agents; Humans; Liver Cirrhosis; Ovarian Neoplasms; Plasminogen; Trypsin Inhibitors; Urokinase-Type Plasminogen Activator | 1975 |
Postoperative thrombosis in Thai women.
Topics: Adult; England; Female; Fibrinogen; Humans; Hysterectomy; Iodine Radioisotopes; Middle Aged; Ovarian Neoplasms; Phlebography; Postoperative Complications; Pulmonary Embolism; Thailand; Thrombophlebitis; Uterine Cervical Neoplasms; Uterine Neoplasms | 1975 |
Immunologic relationship among fibrinolysins secreted by cultured mammalian tumor cells.
Topics: Animals; Cells, Cultured; Female; Fibrin; Fibrinogen; Fibrinolysin; Goats; Immunodiffusion; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Ovarian Neoplasms; Rabbits; Tosylarginine Methyl Ester | 1975 |
Determination of soluble fibrin monomer complexes by adsorption on immobilized fibrinogen.
Topics: Adsorption; Blood Coagulation Tests; Cerebrovascular Disorders; Chromatography, Affinity; Chromatography, Agarose; Ethanol; Female; Fibrin; Fibrinogen; Humans; Ovarian Neoplasms; Solubility; Thrombin | 1978 |
Plasminogen activators in ovarian tumours.
Topics: Biopsy; Female; Fibrin; Fibrinogen; Humans; Ovarian Neoplasms; Ovary; Plasminogen | 1975 |
Role of plasmin in the degradation of the stroma-derived fibrin in human ovarian carcinoma.
Topics: Amino Acid Sequence; Ascitic Fluid; Chromatography, High Pressure Liquid; Cystadenocarcinoma; Electrophoresis, Polyacrylamide Gel; Factor XIII; Female; Fibrin; Fibrinogen; Fibrinolysin; Humans; Molecular Sequence Data; Ovarian Neoplasms; Peptide Hydrolases; Thrombin | 1990 |
[Relation between blood coagulability and prognosis in patients with ovarian cancer].
Topics: Adolescent; Adult; Aged; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Middle Aged; Ovarian Neoplasms; Prognosis; Prothrombin Time; Remission Induction | 1990 |
[Plasma fibrinogen in female patients with genital cancer and its early stage].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Endometriosis; Female; Fibrinogen; Genital Neoplasms, Female; Humans; Middle Aged; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 1985 |
Hemorheological parameters in patients with gynecologic malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Blood Sedimentation; Blood Viscosity; Erythrocyte Aggregation; Female; Fibrinogen; Genital Neoplasms, Female; Hematocrit; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Rheology; Serum Albumin; Serum Globulins; Thrombosis | 1989 |
Early hemostatic disorders in patients with gynecologic tumors.
Topics: Adult; Afibrinogenemia; beta-Thromboglobulin; Blood Coagulation Disorders; Female; Fibrinogen; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Platelet Factor 4; Uterine Cervical Neoplasms; Uterine Neoplasms | 1986 |
Factor VIIIR:Ag plasma levels in patients with cervical and ovarian carcinoma.
Topics: Adult; Aged; Antigens; Factor VIII; Female; Fibrinogen; Humans; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Ovarian Neoplasms; Prognosis; Uterine Cervical Neoplasms; von Willebrand Factor | 1988 |
[Analysis of coagulative and fibrinolytic factors in peripheral and ovarian veins among ovarian cancer patients].
Topics: Adolescent; Adult; Aged; Female; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Humans; Middle Aged; Ovarian Neoplasms; Ovary; Tissue Plasminogen Activator; Veins | 1987 |
[Cerebral ischemic accidents and chronic disseminated intravascular coagulation of cancerous origin].
Topics: Adenocarcinoma; Adult; Cerebral Infarction; Cystadenoma; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Platelet Count; Prothrombin; Urinary Bladder Neoplasms | 1988 |
[A test for the detection of fibrin in the plasma].
Topics: Adult; Antibodies, Monoclonal; Antibody Specificity; Disseminated Intravascular Coagulation; Enzyme-Linked Immunosorbent Assay; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Ovarian Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Pregnancy Complications, Hematologic; Pregnancy Complications, Neoplastic; Pulmonary Embolism; Thrombophlebitis | 1986 |
F.D.P.
Topics: Ascitic Fluid; Female; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Ovarian Neoplasms | 1972 |
Chronic intravascular coagulation syndrome.
Topics: Beta-Globulins; Blood Cell Count; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Chronic Disease; Cryoglobulins; Dipyridamole; Female; Fibrinogen; Heparin; Humans; Immunodiffusion; Immunoelectrophoresis; Middle Aged; Ovarian Neoplasms; Ultracentrifugation; Warfarin | 1968 |
The secretion of fibrinolysin by cultured rat ovarian tumor cells.
Topics: Aminocaproates; Animals; Antifibrinolytic Agents; Centrifugation, Density Gradient; Chromatography, Gel; Clone Cells; Electrophoresis, Polyacrylamide Gel; Female; Fibrinogen; Fibrinolysin; Humans; Immunoelectrophoresis; Macromolecular Substances; Molecular Weight; Ovarian Neoplasms; Ovary; Rats; Trypsin Inhibitors | 1973 |
Fibrin degradation products during postoperative radiotherapy of ovarian carcinoma.
Topics: Adult; Ascitic Fluid; Female; Fibrin; Fibrinogen; Humans; Neoplasm Metastasis; Ovarian Neoplasms; Sertoli-Leydig Cell Tumor | 1973 |
[Comparative investigation of the determination of fibrinogen (author's transl)].
Topics: Abortion, Septic; Blood Coagulation Tests; Female; Fibrinogen; Humans; Infant, Newborn; Ovarian Neoplasms; Postoperative Care; Pregnancy; Pregnancy Complications, Hematologic; Time Factors; Uterine Cervical Neoplasms; Uterine Neoplasms | 1974 |
[Ovarian cancer with diffuse vascular thrombosis. Endocardial, arterial and venous involvement. Disseminated intravascular coagulation with cryofibrinogen].
Topics: Cerebrovascular Disorders; Cold Temperature; Cystadenocarcinoma; Diplopia; Disseminated Intravascular Coagulation; Edema; Encephalomalacia; Endocarditis; Female; Fibrinogen; Foot Diseases; Gangrene; Hemiplegia; Heparin; Humans; Ischemia; Middle Aged; Ovarian Neoplasms; Thrombophlebitis; Thrombosis; Vena Cava, Superior | 1972 |
A study of pulmonary embolism and deep leg vein thrombosis after major gynaecological surgery using labelled fibrinogen-phlebography and lung scanning.
Topics: Adult; Female; Fibrinogen; Genital Diseases, Female; Humans; Hysterectomy; Iodine Radioisotopes; Leg; Methods; Middle Aged; Ovarian Neoplasms; Phlebography; Postoperative Complications; Posture; Pulmonary Embolism; Radionuclide Imaging; Scintillation Counting; Thrombophlebitis; Uterine Cervical Neoplasms; Vulvar Neoplasms | 1974 |